Claire Coutinho
Main Page: Claire Coutinho (Conservative - East Surrey)Department Debates - View all Claire Coutinho's debates with the Cabinet Office
(1 month, 1 week ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Claire Coutinho (East Surrey) (Con)
The Government’s Islamophobia definition is already being weaponised to shut down free speech, just as I warned it would. South Wales police tried to use it to effectively criminalise people for criticising Islam, which Ministers promised us time and again would not happen. Does the Minister understand how divisive that is? If so, will she finally withdraw that dangerous definition?
Bridget Phillipson
South Wales police has paused its plans. It is right that it has done so. There are no blasphemy laws in this country, but it is right that we take action against hatred, prejudice and racism wherever we find it. We have seen shocking examples of Muslims in our country being targeted on the basis of their faith and because of who they are. We need look no further than the shadow Justice Secretary, the hon. Member for West Suffolk (Nick Timothy), who engaged in appalling racism towards Muslims in our country and, rather shamefully, was not sacked by the Leader of the Opposition for those comments.
Claire Coutinho
Asking officers to record examples of an illegitimate criticism of Islam is nothing short of an assault on free speech. Let me try another issue: last night, Labour MPs voted to give children as young as 11 powerful puberty-blocking drugs that could leave them infertile for the rest of their lives. The right hon. Lady is the Cabinet Minister for children and she knows that children in the care system are over-represented in that group. This cannot sit right with her. Will she do the right thing and tell the Health Secretary to stop the puberty-blocking trial?
Bridget Phillipson
When Dr Hilary Cass published her review, we endorsed all those recommendations, as did the Conservatives. An important part of what Dr Cass set out was that it is essential that healthcare is available to children and young people who are experiencing gender dysphoria or incongruence, but that it must be safe, evidence-based and clinically appropriate. We have always been clear about the red lines regarding the Medicines and Healthcare products Regulatory Agency’s trial and the prescription of puberty blockers, and the safety and wellbeing of children must be at the forefront of everything that we do, but the review by Dr Cass concluded that while not enough was known about the safety of puberty-suppressing hormones, it was necessary to take forward a trial.